首页> 外文会议>Molecular-Guided Surgery: Molecules, Devices, and Applications V >Efficacy of indocyanine green-loaded hyaluronic acid nanoparticles for the surgical resection of orthotopic breast tumors
【24h】

Efficacy of indocyanine green-loaded hyaluronic acid nanoparticles for the surgical resection of orthotopic breast tumors

机译:吲哚菁绿载玻尿酸纳米颗粒在原位乳腺肿瘤手术切除中的疗效

获取原文
获取原文并翻译 | 示例

摘要

Breast cancer patients that experience complete removal of the primary tumor, or negative surgical margins (NSMs),benefit from decreased rates of local recurrence and increased survival. However, intraoperative margin detection islimited to visualization, palpation, and experience to identify malignant vs. healthy tissue. As a result, roughly 1/3 ofpatients treated with breast conserving surgery (BCS) have residual cancer cells left at the resection border, or positivesurgical margins (PSMs). Fluorescence image-guided surgery (FIGS) is a promising alternative for intraoperative margindetection, providing surgeons with real-time feedback on tumor location, increasing the likelihood of achieving NSMs.Our past work has demonstrated that the use of self-assembled hyaluronic acid (HA) nanoparticles improves the deliveryof indocyanine green (ICG) to breast tumors, enhancing intraoperative tumor signal and contrast. This study built uponthese findings by assessing the surgical efficacy of ICG-loaded HA nanoparticles (NanoICG) for the image-guidedresection of orthotopic iRFP+/luciferase+ 4T1 breast tumors in BALB/c mice. Tumors were resected with FIGS in micetreated with ICG or NanoICG and compared to bright light surgery (BLS) or sham controls. Tumor growth andrecurrence were monitored with bioluminescence imaging. NanoICG improved complete resection and prolonged tumorfreesurvival. Additionally, NanoICG provided greater intraoperative contrast in malignant tissue than ICG or BLS.Furthermore, NanoICG demonstrated a greater ability to identify small, occult lesions than ICG. Overall, the use ofNanoICG for the fluorescence image-guided resection of breast tumors could potentially decrease PSM rates andimprove complete tumor removal.
机译:乳腺癌患者经历了原发肿瘤的完全切除或手术切缘阴性(NSMs),\\从局部复发率降低和生存率提高中受益。但是,术中切缘检测仅限于可视化,触诊和识别恶性组织与健康组织的经验。结果,大约1/3接受保乳手术(BCS)的患者在手术切除边界处残留了癌细胞,或手术边缘(PSMs)阳性。荧光图像引导手术(FIGS)是术中切缘检测的有希望的替代方法,可为外科医生提供有关肿瘤位置的实时反馈,增加了实现NSM的可能性。\ r \ n我们过去的工作表明,使用自组装透明质酸(HA)纳米颗粒可改善吲哚菁绿(ICG)向乳腺肿瘤的递送,增强术中肿瘤信号和对比度。这项研究基于这些发现,通过评估ICG负载的HA纳米颗粒(NanoICG)对BALB / c小鼠原位iRFP + /萤光素酶+ 4T1乳腺肿瘤的图像引导切除术的疗效。用ICG或NanoICG治疗的小鼠体内的无花果切除肿瘤,并与强光手术(BLS)或假对照组进行比较。用生物发光成像监测肿瘤的生长和复发。 NanoICG改善了完整切除的效果并延长了无瘤生存期。此外,与ICG或BLS相比,NanoICG在恶性组织中提供了更大的术中对比。\ r \ n此外,与ICG相比,NanoICG表现出更大的识别微小隐匿性病变的能力。总体而言,使用\ r \ nNanoICG进行乳腺肿瘤的荧光图像引导切除可能会降低PSM率并改善整个肿瘤的清除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号